Bacteriostatic water per vial isn't a fixed pour — it's back-calculated from peptide mass and the target stock concentration a protocol requires. Most research-grade lyophilized peptide vials take 1mL to 5mL of bacteriostatic water, with 2mL the most common volume across 2mg to 10mg vials reconstituted to a 1mg/mL to 5mg/mL stock concentration under current 2026 laboratory practice. The volume itself is never set by the vial — it's derived from peptide mass divided by the target concentration a specific assay needs, and skipping that calculation is the most common gap flagged during analytical review of reconstitution records.
- Bacteriostatic water per vial is calculated, not fixed: volume (mL) = peptide mass (mg) divided by target concentration (mg/mL).
- A 5mg vial reconstituted to 2mg/mL stock needs 2.5mL of bacteriostatic water; to 5mg/mL it needs 1mL.
- Vial fill capacity, not habit, sets the practical ceiling on how much bacteriostatic water per vial gets added.
- Document the exact volume added against the lot number every time — undocumented reconstitution volumes fail analytical review.
Why this matters
A reconstitution volume that isn't traceable to a documented calculation is a research record with a hole in it. Analytical review during a quality check compares the peptide mass on the lot's certificate of analysis against the volume of bacteriostatic water actually added — if that math isn't recorded, the stock concentration used in every downstream measurement is unverifiable.
Reconstitution volume decisions sit inside the same Define-Plan-Produce-Verify-Document sequence used for other laboratory documentation: define the target concentration the protocol calls for, plan the volume against peptide mass, produce the stock solution, verify it against the certificate of analysis, and document the specific volume against the lot record. Simple Life Science ships lyophilized peptides with a defined mass per vial and a lot-specific certificate of analysis, which is the input figure this whole calculation depends on. A bacteriostatic water comparison for peptide reconstitution is worth reviewing before setting a standing volume across a study, since preservative concentration and grade differ between suppliers.
How much bacteriostatic water should you add per vial?
The formula is fixed even though the answer per vial isn't: volume (mL) = peptide mass (mg) ÷ target concentration (mg/mL). Once the target concentration for the protocol is set, the volume follows directly from the mass printed on the vial and confirmed on the lot's certificate of analysis.
| Peptide mass in vial | Target stock concentration | Bacteriostatic water to add |
|---|---|---|
| 2mg | 1mg/mL | 2mL |
| 2mg | 2mg/mL | 1mL |
| 5mg | 1mg/mL | 5mL |
| 5mg | 2mg/mL | 2.5mL |
| 5mg | 5mg/mL | 1mL |
| 10mg | 2mg/mL | 5mL |
| 10mg | 5mg/mL | 2mL |
The same 5mg vial produces four different bacteriostatic water volumes depending on the concentration the protocol specifies — the vial mass never changes, only the target concentration does.
“Volume follows the target concentration, not vial habit — recalculate for every peptide mass and every protocol.”
2mg vial at 1mg/mL stock concentration: add 2mL
A 2mg vial reconstituted to a 1mg/mL stock takes 2mL of bacteriostatic water. This is the lowest-mass, lowest-concentration combination in common use and leaves the most headroom against typical vial fill capacity.
5mg vial at 2mg/mL stock concentration: add 2.5mL
A 5mg vial reconstituted to a 2mg/mL stock takes 2.5mL of bacteriostatic water. This is the most frequently documented combination across mid-mass research vials because it balances a workable stock concentration against standard vial headspace.
10mg vial at 5mg/mL stock concentration: add 2mL
A 10mg vial reconstituted to a 5mg/mL stock takes 2mL of bacteriostatic water. Higher-mass vials reconstituted to higher concentrations use less diluent per milligram, which matters when vial fill capacity is the limiting factor.
Why the volume varies
The volume added per vial moves for a defined set of reasons, not by convention:
- Peptide mass stated on the vial label, confirmed against the lot's certificate of analysis before any volume is calculated
- Target concentration required by the specific assay or protocol the stock solution will feed into
- Total internal volume the vial can hold without overflow or headspace loss during reconstitution
- Sequence-specific solubility limits for larger or more hydrophobic peptides, which can require more diluent to fully dissolve at a given mass
- Downstream analytical method, since an HPLC dilution series or a plate-based assay may call for a secondary dilution rather than a higher initial volume
- Storage and stability window once the peptide is in aqueous solution, which factors into how concentrated the stock needs to be at the point of use
Water quality itself is one of these variables. Reconstituting peptides with tap water introduces uncontrolled mineral content and microbial load that bacteriostatic water is specifically formulated to avoid — the volume calculation assumes a defined-purity diluent, and substituting an undefined water source breaks that assumption regardless of the math.
Request reconstitution lot documentation
Get analytical review and lot records tied to bacteriostatic water pairing.
Related questions researchers ask
Does adding more bacteriostatic water dilute peptide stability?
Adding more bacteriostatic water lowers the stock concentration in direct proportion to volume — a 5mg vial diluted to 5mL yields a 1mg/mL stock instead of a 5mg/mL stock. It doesn't change the peptide's chemical stability; it only changes the concentration read on every downstream measurement, which is why the target concentration has to be fixed before the volume is chosen, not after.
Can the same bacteriostatic water vial supply more than one peptide vial?
A single bacteriostatic water vial can supply multiple peptide vials, provided sterile technique is preserved on each draw and the withdrawn volume is logged against each specific peptide lot. Many labs apply a 28-day discard window after first puncture for multi-dose bacteriostatic water vials, following common multi-dose vial handling conventions, so the number of draws and the elapsed time both belong in the record.
What happens if too little bacteriostatic water is added to a vial?
Too little bacteriostatic water produces a stock concentration higher than the target, which throws off any subsequent dilution series built on that assumed concentration. If the peptide fails to fully dissolve at the reduced volume, that's a sign of peptide degradation or a solubility mismatch worth checking against the lot's analytical characterization before proceeding.
Preguntas frecuentes
How much bacteriostatic water should you add per vial?
The volume equals peptide mass in mg divided by target concentration in mg/mL — a 5mg vial taken to a 2mg/mL stock needs 2.5mL of bacteriostatic water. There is no single default volume; it changes with both the vial’s peptide mass and the concentration the protocol specifies.
Is bacteriostatic water the same as sterile water for reconstitution?
No — bacteriostatic water contains a preservative, typically benzyl alcohol, that sterile water for injection does not, which allows repeated draws from the same vial. Sterile water without a preservative is intended for single-use reconstitution only.
Can you add more bacteriostatic water than the vial’s original fill volume?
Adding a volume that exceeds the vial’s practical headspace risks overflow or pressure buildup when the stopper is repunctured. Vial fill capacity, not the concentration formula alone, sets the practical upper limit on volume added.
Does peptide mass or vial size determine the water volume needed?
Peptide mass, confirmed against the certificate of analysis, is the input to the volume formula — vial size only sets the ceiling on how much diluent physically fits. Two vials of the same physical size can require different volumes if their peptide mass differs.
How long does a reconstituted peptide stock stay usable at a given concentration?
Stability windows depend on the specific peptide, storage temperature, and preservative in the diluent, and vary by lot and protocol. Refrigeration guidance for reconstituted peptide stocks is protocol-specific and should be checked against the lot’s documentation rather than assumed.
Can bacteriostatic water calculations be reused across different peptide sequences?
No — solubility and target concentration are sequence-specific, so a volume that works for one peptide mass and sequence does not transfer directly to another. Each peptide’s mass and the protocol’s target concentration have to be recalculated independently.
Does bacteriostatic water need to match the peptide’s molecular weight for the calculation?
No — the volume formula uses peptide mass in milligrams and target concentration in mg/mL, not molecular weight. Molecular weight matters for molar concentration calculations, which are a separate step from the mass-based dilution most reconstitution protocols specify.
One last thing
The volume calculation gets the attention; the discard clock after first puncture usually doesn't. A bacteriostatic water vial opened on day one and drawn from repeatedly through day 30 has a different documentation status than one opened and used once — the 28-day convention common to multi-dose vial handling applies to the diluent vial itself, independent of how carefully the mg-to-mL math was done on any single peptide vial it was used to reconstitute. Track both dates, not just one.
Related guides
- How long reconstituted peptides stay refrigerated
- Automatically log reconstitution when bacteriostatic water ships
